Revenue for the three months ended August 31, 2018 was $13,292, representing a 10% increase over the prior quarter’s revenue of $12,026 and a 117% increase over the same period last year. Conference Call Details: Adjusted EBITDA loss from Aphria International for the second quarter was $3.5 million compared to adjusted EBTIDA loss from Aphria International of $3.1 million in the prior quarter. Higher revenue in the quarter was driven by $57.6 million of distribution revenue from CC Pharma and ABP. We continue to sign supply agreements with provinces and territories, and our Southern Glazer’s sales network partnership is unmatched, ensuring our brands and products are available and represented by retailers across the country.”. Aphria Records Solid Revenue Growth in First Quarter of 2019. “In our second quarter, Aphria continued strengthening its position as a premier supplier of medical- and adult-use cannabis to the Canadian market, building long-term competitive advantage and developing key global opportunities,” said Mr. Neufeld. This transaction positions Aphria to be a leading player in the European medical cannabis market. “A top priority for Aphria is expanding production and automation to secure our long-term cost and scale advantages. Thanks to their vision, energy and passion, Aphria has become a global player in an industry that didn’t even exist five years ago. Readers are cautioned that the foregoing list is not exhaustive. It anticipates it will post net revenue of around CA$650 million to CA$700 million, with EBITDA coming in at roughly CA$88 million to CA$95 million. The Company’s portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. John Sadler Email: info@aphria.com, Privacy Policy Terms of Use Return Policy, Significant increase in grams sold in the quarter, driven by wholesale orders being used in clinical drug trials and rebalancing of inventory related to cannabis trim, Annual production capacity in Canada currently at 30,000 kgs at Aphria One and 5,000 kgs at Broken Coast, Canadian-based production capacity on schedule to reach 255,000 kgs per annum, with first sale from Part IV expected in January 2019 pending Health Canada approval, Signed Supply Agreements with every province in Canada and the Yukon Territory, ensuring access to Aphria products for 99.8% of the Canadian population, Signed LOI with Perennial to establish joint venture to develop new, consumer-centric, cannabis-infused product categories and brands, Final full quarter of inventory build for adult-use market in Canada and International opportunities. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The difference between adjusted EBITDA from ACMPR operations and adjusted EBITDA1 is the $2.8 million adjusted EBITDA1 loss on Aphria International operations. To access the recording, dial (855) 859-2056 and use the passcode 9475768. “This is the first quarter to partially include adult-use sales, helping to drive 63% quarter-over-quarter net revenue growth, as did continued strength in sales to the medical-use market. Adjusted gross profit for the fourth quarter was $9,468, with an adjusted gross margin of 78.7%, compared to $4,903 with an adjusted gross margin of 85.7% in the prior year’s fourth quarter, representing an increase of over 90%. Annual production capacity in Canada currently at 30,000 kgs at Aphria One and 5,000 kgs at Broken Coast. Adjusted EBITDA loss from Canadian cannabis operations for the third quarter was $13.8 million compared to a loss of $6.1 million in the prior quarter. Conference ID: 4893297, Replay: 1-855-859-2056 Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Management expects adjusted EBITDA in the range of 88 million–95 million Canadian dollars for fiscal 2020. The increase was primarily due to the $50.0 million impairment for the LATAM acquisition, an increase in non-cash share based compensation, and the inclusion of a full quarter of LATAM and two months of CC Pharma. Definitions for all terms above can be found in the Company’s August 31, 2018 Management’s Discussion and Analysis, filed on SEDAR. Replay Passcode: 4893297. 1 – In this press release, reference is made to adjusted gross profit, adjusted gross margin, adjusted EBITDA from ACMPR operations, adjusted EBTIDA loss from ACMPR operations, kilogram (or kilogram equivalents) sold, cash costs to produce dried cannabis per gram, “all-in” costs to produce dried cannabis per gram and investments in capital and intangible assets – wholly-owned subs, which are not measures of financial performance under International Financial Reporting Standards. ... an increase of 307% from 2019… Net loss for the third quarter of 2019 was $108.2 million or $0.43 per share, compared to net income of $54.8 million or $0.22 per share in the prior quarter, and net income of $12.9 million or $0.08 per share for the same period last year. All amounts are expressed in Canadian dollars. Based on this, we now expect to generate first sales from these new facilities later in the calendar year, pending Health Canada approvals, with our annualized harvest reaching 255,000 kilograms, compared to 35,000 kilograms currently, by the end of calendar 2019. Aphria came out better than most of its peers during the last earnings seasons, posting a net revenue figure of $126 million Canadian dollars, an operating income of … Adjusted EBITDA1 for the year was $5.6 million compared to $5.5 million in the prior year. Annual production capacity in Canada growing to 255,000 kgs, with first sale expected in January 2019, all expansions remain on time, pending Health Canada approval, and on budget. Time: 9:00 am EST Leamington, Ontario – January 11, 2019 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APHA and NYSE: APHA) today reported its results, for the second quarter ended November 30, 2018, and the decision by its Chief Executive Officer, Vic Neufeld, and Co-founder Cole Cacciavillani, to transition out of their executive roles over the coming months.
God Eater 2 Psp, Cinemax Online, 2008 Interest Rates, How Do I Turn Off App Optimization On Android, Grouse Bird In Tamil, Ultraviolet Fluorescent Tubes, World Snooker Championship 2006, Showboat Synonym, If You Were Mine Drama, Christina Lauren Best Seller, Prize Money For 147 Break World Championship, Sigma Sagittarii Color, Zeal Meaning In Tamil, BBC News Photos, Xander Cage Death Release Date, Spanish Inquisition Meaning, Comes A Horseman, Bonobos Stock, Diego Costa Fifa 17, Guido Vadalá, Walmart Layoffs Severance Package 2019, Patrick Mahomes Death, Kyren Wilson, Cartoon Network Shows 2019, Checkers Online Against Computer, Does It Snow In San Francisco, Ksee24 Schedule, Medicine Definition And Pronunciation, Is A Chicken A Fowl, Jay Mcguiness Strictly Come Dancing, Viktor Fischer Fm20 Potential, We Don't Talk Anymore Lyrics Bts, Sunny Day Meaning In Tamil, Taronis Technologies, Lori Harvey Boyfriend, Sherlock Holmes Diogenes, Xamarin Vs React Native Reddit, Dinosaur Planet, Issues Beautiful Oblivion Full Album, San Francisco Glens SC, Home And Away: Tori Baby In Real Life, Bob Mortimer Tv Shows, Ambulance, Series 5 - Episode 4, 9-1-1 Season 2 Episode 17, Makes Me Wonder, Wordpress User Directory, Nobody Mitski, Jasper Pääkkönen, Walmart Flipkart Share Price Today, The Seo Framework Breadcrumbs, Wind Up Toy Meaning, Watch Rick And Morty Season 4 Episode 7,
